Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

DALIRESP vs YUPELRI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. DALIRESP and YUPELRI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

dalirespyupelri

Rating

70/100
New

Pharmacy pays

~$10.09 /30
—

Type

RX
RX

Active ingredient

ROFLUMILAST
REVEFENACIN

Manufacturer

Astrazeneca
Mylan Ireland Ltd

Dosage forms

Tablet
Solution

Drug class

Phosphodiesterase 4 Inhibitor
—

Boxed warning

None
None

Treats

Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease

Frequently asked questions

What is the difference between Daliresp and Yupelri?

Daliresp contains Roflumilast, while Yupelri contains Revefenacin — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.